Answers are grounded in this paper and cite their sources.
Twinrix (GlaxoSmithKline Biologicals, Rixensart, Belgium) is the first combined vaccine to provide protection against both hepatitis A and B. This review presents a critical analysis of antibody responses stratified by age following vaccination with Twinrix in 264 adults aged above 40 years. A month after completion of a 0-, 1-, 6-month vaccination schedule with Twinrix, a good response was observed for both anti-HAV and anti-HBs serum antibodies, suggesting that is an effective vaccine in older adults.
No takes yet. Share an insight, caveat, or question.
Stoffel et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: